1. Home
  2. CATY vs CDTX Comparison

CATY vs CDTX Comparison

Compare CATY & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cathay General Bancorp

CATY

Cathay General Bancorp

HOLD

Current Price

$49.87

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Cidara Therapeutics Inc.

CDTX

Cidara Therapeutics Inc.

HOLD

Current Price

$220.29

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATY
CDTX
Founded
1962
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CATY
CDTX
Price
$49.87
$220.29
Analyst Decision
Hold
Buy
Analyst Count
5
13
Target Price
$50.80
$119.44
AVG Volume (30 Days)
370.5K
2.2M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
2.72%
N/A
EPS Growth
9.40
N/A
EPS
4.33
N/A
Revenue
$711,617,000.00
N/A
Revenue This Year
$18.83
N/A
Revenue Next Year
$8.37
N/A
P/E Ratio
$11.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.06
$15.22
52 Week High
$52.43
$221.20

Technical Indicators

Market Signals
Indicator
CATY
CDTX
Relative Strength Index (RSI) 63.12 88.29
Support Level $47.89 $219.36
Resistance Level $50.45 $221.20
Average True Range (ATR) 1.28 0.95
MACD 0.32 -1.18
Stochastic Oscillator 90.41 82.06

Price Performance

Historical Comparison
CATY
CDTX

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Share on Social Networks: